STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$13.57
+2.73%Price chart
Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6
Key dataNov 6, 2026
Open$13.23
From 52W high−44.41%
Volume1.37M
Market cap$3.71B
P/E (TTM)23.7x
P/S (TTM)2.7x
Div yield0.46%
Key dataNov 6, 2026
Open
$13.23
From 52W high
−44.41%
Volume
1.37M
Market cap
$3.71B
ValuationView details →
P/E (Fwd)
18.3x
EV/EBITDA
12.0x
P/E (TTM)
23.7x
RSI (14)
19.2
MomentumView details →
1D Return
+2.73%
YTD Return
−34.84%
SummaryUpdated Sep 1, 2026
Stevanato Group S.p.A. (NYSE:STVN) is an Italian pharmaceutical packaging and equipment company founded in 1949 and headquartered in Piombino Dese, Italy. The company went public in July 2021 and operates as a subsidiary of Stevanato Holding S.R.L. Stevanato has evolved from a traditional glass manufacturer into a leading provider of integrated solutions for the pharmaceutical and healthcare industries, specializing in drug containment, delivery systems, and manufacturing equipment. The company serves global pharmaceutical companies through manufacturing facilities in Italy, the United States, and other international locations.
Similar companies
Latest newsMore news →
Holzer & Holzer, LLC announced an investigation into whether Stevanato Group S.p.A. complied with federal securities laws.3d agoStevanato Group's stock price dropped following the company's third-quarter results and earnings call.3d agoStevanato Group reported that GLP-1-related revenue decreased in the third quarter of 2026 and represented approximately 17% to 18% of total company revenue.3d ago